Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03141736
Other study ID # F150807004
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date November 19, 2024
Est. completion date October 12, 2025

Study information

Verified date November 2022
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether the combination of Kangaroo Mother Care (KMC) as continuously as possible together with the use of a plastic bag in combination with routine World Health Organization (WHO) thermoregulation care reduces the incidence of moderate (32-36° C) or severe (<32.0° C) hypothermia in preterm infants ≥ 32 to 36 6/7 weeks of gestational age (GA) when compared to KMC as continuously as possible together with routine WHO thermoregulation care.


Description:

The purpose of this study is to determine whether the combination of Kangaroo Mother Care (KMC) as continuously as possible together with the use of a plastic bag in combination with routine World Health Organization (WHO) thermoregulation care (warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling) reduces the incidence of moderate hypothermia (32-36° C) or severe (<32.0° C) in preterm infants ≥ 32 to 36 6/7 weeks of gestational age (GA) when compared to KMC as continuously as possible together with routine WHO thermoregulation care, as practiced. The investigators are proposing two trials, one protocol for infants 32-36 6/7 weeks (this one) and one for infants who are ≥37 weeks gestational age. This preterm infant trial will address the effectiveness of KMC in combination with plastic bags in decreasing hypothermia in preterm infants. The proposed trial will determine whether KMC with plastic bags prevents hypothermia in neonates born in a healthcare setting with limited resources where a high risk for hypothermia has been reported. Any intervention that decreases morbidity during the neonatal period has the potential to impact health beyond the neonatal period,and one that is highly cost-effective and easy to use is more likely to be implemented in the developing world.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date October 12, 2025
Est. primary completion date October 12, 2025
Accepts healthy volunteers No
Gender All
Age group 10 Minutes to 2 Hours
Eligibility Inclusion Criteria: - Estimated gestational age =32 0/7 - 36 6/7 weeks - Delivery in the hospital Exclusion Criteria: - Abdominal wall defect or myelomeningocele - Major congenital anomalies - Blistering skin disorder - Clinically unstable mothers secondary to cardiovascular and pulmonary conditions - Infants requiring respiratory support beyond 10 minutes after birth - Infant requiring NICU admission - C/section - Multiple gestation if the last delivering infant is not born within 10 minutes from the time of birth of the first infant

Study Design


Intervention

Other:
KMC & WHO protocol (0-1 hour)
WHO thermoregulation care - warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling
KMC, WHO protocol & bag (0-1 hour)
In addition infants will be placed in a plastic bag (clear polyethylene non-medical low-cost [3 cents per bag]
KMC & WHO protocol (1-24 hours)
WHO thermoregulation care - warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling
KMC, WHO protocol & bag (1-24 hours)
In addition infants will be placed in a plastic bag (clear polyethylene non-medical low-cost [3 cents per bag]

Locations

Country Name City State
Zambia University Teaching Hospital Lusaka

Sponsors (2)

Lead Sponsor Collaborator
University of Alabama at Birmingham University Teaching Hospital, Lusaka, Zambia

Country where clinical trial is conducted

Zambia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Moderate or severe hypothermia at 1 hour after birth (Phase 1A) Moderate (32.0-35.9C) or severe (<32.0C) hypothermia at 1 hour after birth (via axillary temperature) 1 hour after birth
Primary Moderate or severe hypothermia at 24 hours or discharge (Phase 1B) Moderate (32.0-35.9C) or severe (<32.0C) hypothermia at 24 hours or discharge whichever occurs first (via axillary temperature) 1 to 24 hours after birth
Secondary Any hypothermia at 1 hour after birth (Phase 1A) Any hypothermia (<36.5C) at 1 hour after birth 1 hour after birth
Secondary Any hypothermia at 24 hours or discharge (Phase 1B) Any hypothermia (<36.5C) at 24 hours or discharge, whichever occurs first 1 to 24 hours or discharge
Secondary Hyperthermia at 1 hour after birth (Phase 1A) Hyperthermia (>38.0C) at 1 hour after birth 1 hour after birth
Secondary Hyperthermia at 24 hours or discharge (Phase 1B) Hyperthermia (>38.0C) at 24 hours or discharge, whichever occurs first 1 to 24 hours or discharge
Secondary Skin rash Skin rash (at 1hour and before discharge) 1hour to 24 hours or discharge, or whichever occurs first
Secondary Neonatal Intensive Care Unit admission Neonatal Intensive Care Unit admission (at 1 hour and before discharge) 1hour to 24 hours or discharge, or whichever occurs first
Secondary Respiratory distress syndrome Diagnosis of respiratory distress syndrome (at 1 hour and before discharge) 1hour to 24 hours or discharge, or whichever occurs first
Secondary Sepsis Diagnosis of sepsis (at 1hour and before discharge) 1hour to 24 hours or discharge, or whichever occurs first
Secondary Hypotension, hypoglycemia or seizure Diagnosis of any of the following; hypotension, hypoglycemia or seizure (at 1hour and before discharge) 1hour to 24 hours or discharge, or whichever occurs first
Secondary Death Death (at 1hour and before discharge) 1hour to 24 hours or discharge, or whichever occurs first
Secondary Maternal body temperature Maternal body temperature in Celsius At birth, at 1 hour, every four hours until 24 hours or discharge, whichever occurs first
Secondary Duration of KMC and plastic bag to infant's body temperature Correlation analysis between duration of KMC +/- plastic bag in minutes to infant's body temperature in Celsius During first 1 hour
Secondary Duration of KMC and plastic bag to infant's body temperature Correlation analysis between duration of KMC +/- plastic bag in minutes to infant's body temperature in Celsius During first 24 hours or discharge, or whichever occurs first
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Completed NCT02993744 - Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone N/A
Active, not recruiting NCT02673216 - Infection and Adverse Pregnancy Outcome
Completed NCT01683565 - Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood Phase 4
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT01412931 - Protein and Ultrasound Indicators of Preterm Birth N/A
Completed NCT02606058 - The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? N/A
Terminated NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women N/A
Completed NCT00422526 - Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial Phase 3
Enrolling by invitation NCT04251260 - Effectiveness of Positioning in Preterm Neonates N/A
Completed NCT03668860 - India Dexamethasone and Betamethasone Phase 1
Recruiting NCT03638037 - Correlation Between Maternal Vitamin D Level And Preterm Birth
Completed NCT02225353 - Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Phase 2
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT03144141 - Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery N/A
Completed NCT05210985 - Examination of the Relationship Between Home Affordances With Development
Completed NCT04811742 - Effect of Immersion Bathing and Showering Applications on Comfort Level and Physiological Parameters of Newborn N/A